pirinixic acid has been researched along with nitroarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulhak, AA; Edvinsson, L; Pernow, J; Sjöquist, PO; Xu, CB | 1 |
| Bulhak, AA; Jung, C; Lundberg, JO; Ostenson, CG; Pernow, J; Sjöquist, PO | 1 |
2 other study(ies) available for pirinixic acid and nitroarginine
| Article | Year |
|---|---|
Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Topics: Animals; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Heart Rate; Immunoblotting; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2006 |
PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Topics: Androstadienes; Animals; Blood Glucose; Body Weight; Cardiotonic Agents; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Insulin; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; PPAR alpha; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rats, Wistar; Signal Transduction; Wortmannin | 2009 |